# Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantation

> **NCT02512718** · PHASE1 · COMPLETED · sponsor: **Alexandra N. Carey** · enrollment: 20 (actual)

## Conditions studied

- Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** Omegaven
- **DRUG:** Soybean oil lipid emulsion

## Key facts

- **NCT ID:** NCT02512718
- **Lead sponsor:** Alexandra N. Carey
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2023-05-18
- **Final completion:** 2023-05-18
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02512718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02512718, "Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02512718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*